Medicine & Life Sciences
Urokinase-Type Plasminogen Activator
100%
Small Cell Lung Carcinoma
94%
Interleukin-8
69%
Doxorubicin
63%
apolipoprotein E-rich HDL
56%
Thrombomodulin
56%
Lymphoma
53%
lavender oil
53%
Anticoagulants
44%
Retinoids
43%
Camptothecin
40%
Retinoic Acid Receptors
40%
Myeloid Leukemia
40%
Philadelphia Chromosome
39%
Tretinoin
39%
Volatile Oils
37%
VLX1570
35%
Imatinib Mesylate
35%
Leukemia
33%
fudosteine
32%
Acute Promyelocytic Leukemia
31%
Human Umbilical Vein Endothelial Cells
30%
Precursor Cell Lymphoblastic Leukemia-Lymphoma
30%
linalyl acetate
29%
Chemokine CCL2
27%
Chemokine CCL26
26%
Asthma
26%
CC Chemokines
26%
Thromboplastin
25%
Chromosome 5q Deletion Syndrome
25%
CXC Chemokines
25%
Hot Springs
24%
Mutation
23%
Mitogen-Activated Protein Kinases
23%
Matrix Metalloproteinase 8
22%
Anthracyclines
22%
Reactive Oxygen Species
22%
Radon
22%
Carcinoma
21%
p38 Mitogen-Activated Protein Kinases
21%
Messenger RNA
21%
Chemotactic Factors
21%
Lung
20%
Matrix Metalloproteinase 9
20%
Inflammation
19%
Up-Regulation
19%
Megakaryocytes
18%
Ploidies
18%
ATP-Binding Cassette Transporters
18%
Chemical Compounds
High-Density Lipoprotein
39%
Apolipoprotein
37%
Anticoagulant
37%
Retinoid
34%
Essential Oil
30%
Linalyl Acetate
24%
Retinoic Acid
23%
Chemoattractant
22%
Serum Level
21%
Vitamin D
19%
Antiinflammatory
18%
Doxorubicin
16%
Fluorescence Microscopy
15%
Superoxide
15%
Cholesterol
13%
Lipoprotein
13%
Mutation
13%
Metabolic
12%
Antioxidant Agent
10%
Plasma
9%
Conditioned Culture Medium
8%
Haematological
8%
Tyrosine Kinase Inhibitor
7%
High-Density Lipoprotein Cholesterol
7%
Antigen
6%
Retinoic Acid Receptor Antagonist
6%
Pyrrolidine Dithiocarbamate
5%
Anthracycline
5%
Chain Reaction
5%